Description and Brand Names
Drug information provided by: IBM Micromedex
Dostarlimab-gxly injection is used to treat endometrial cancer (cancer of the lining of the uterus or womb) that is mismatch repair deficient (dMMR) in patients whose cancer has returned, or it has spread or cannot be removed by surgery. It is given to patients who have received other cancer medicines (eg, platinum) that did not work well. Your doctor will perform a test to check for the dMMR tumor before you use this medicine.
Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms: